Delivery Order SPE2DB20D2014-SPE2DB25FC76G
Award Date 8/15/25
Potential Completion Date 8/18/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,282.84 to AmerisourceBergen Drug Corp for the supply of Glycopyrrolate 1 mg/5 ml vials (5 ml units). This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by May 20, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Glycopyrrolate Inject on June 25, 2024, with a ceiling value of $2,381.99 and a completion date of July 25, 2024. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The contract was performed at the vendor's corporate office location in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Glycopyrrolate 4 mg/20 ml vials with a ceiling value of $1,083.71. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, and carries an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Glycopyrrolate 0.2 mg/mL in 5 mL vials, with a ceiling value of $14,491.55 and an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be fulfilled at the contractor's Conshohocken, Pennsylvania facility. The award falls under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $6,379.02 delivery order to AmerisourceBergen Drug Corp for Glycopyrrolate Inject, with an ultimate completion date of June 26, 2024. This non-set-aside, firm fixed price contract was competitively awarded on June 25, 2024, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical transaction within the company's broader federal medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GLYCOPYRROLATE 4 MG/20 ML VIAL 20ML, a pharmaceutical product. The total ceiling value of the contract is $1,251.23 and the ultimate completion date is June 5, 2025. This is an unrestricted contract with no set-aside designation. AmerisourceBergen Drug Corp holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $6,539.83, is for the supply of 4563402308 - Glycopyrrolate 0.5 mg/mL vials. The contract type is Firm Fixed Price and has an ultimate completion date of January 23, 2024. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. government has awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of GLYCOPYRROLATE INJECT medication. The contract, valued at $7,907.16, has an ultimate completion date of July 7, 2023 and was awarded on July 6, 2023 by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,241.53 fixed-price contract is for the delivery of Glycopyrrolate 0.2 mg/ml vial, a medication used to treat certain conditions. The contract has a completion date of June 12, 2025 and is not set aside for any specific business category. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4564246806 - GLYCOPYRROLATE 0.2 MG/ML VIAL 20ML. The contract has a ceiling value of $2,349.10 and a completion date of April 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...